BPOM enables the dengue vaccine to get started circulating, anticipating dengue sickness

Metropolis OF BALIKPAPAN – The Food items and Drug Supervisory Company (BPOM) has granted the marketing and advertising authorization for vaccine Dengue under the name Qdenga, starting right now Friday 9 September 2022.

For your facts, Qdenga is vaccine with indications in the prevention of dengue disorder brought on by the dengue virus at the age of 6 to 45 yrs.

The vaccine is manufactured by IDT Biologika GmbH Germany. Then issued and registered on behalf of Takeda GmbH Germany.

Study also: Apparently the simply call to prayer was not from the Prophet, it started from a friend’s aspiration, this is the total tale

The Qdenga vaccine is a vaccine Dengue according to permitted by BPOM article Dengvaxia (registered beneath the title of PT Aventis Pharma).

In accordance to BPOM, vaccine Qdenga is a sort of live attenuated tetravalent Dengue Vaccine (TDV) consisting of 4 viral strains Dengue.

Among the other issues, strains Dengue attenuated serotype 2 (TDV-2), recombinant pressure Dengue serotype 2/1 (TDV-1), recombinant strain Dengue serotype 2/3 (TDV-3).

Go through also: How to employ a healthy way of living, check out out these added benefits

And recombinant strain Dengue serotype 2/4 (TDV). -4).

In the meantime, vaccine TDV-2 pressure created by Virus Dengue form two attenuated (attenuated).

–